Skip to content

ImmunityBio, Inc. IBRX Inventory turnover

Inventory turnover at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
5.3×+0.3×
Johnson & Johnson logo
Johnson & JohnsonJNJ
2.3×-0.1×
Merck & Co. logo
Merck & Co.MRK
3.2×-0.6×
Gilead Sciences logo
Gilead SciencesGILD
2.8×-0.8×
Incyte logo
IncyteINCY
1.2×+0.1×
Exelixis logo
ExelixisEXEL
1.2×+0.2×

Other financials

Income statement

See full
Revenue$44.2M+168%
Gross profit$44.0M+167%
Operating income-$69.8M-8.3%
Net income-$632.8M-388%
EPS (diluted)-$0.62-313%

Balance sheet

See full
Cash & equivalents$205.2M+238%
Total debt$445.4M+32.2%
Total equity-$870.0M-47.1%
Total assets$646.6M+113%

Cash flow

See full
Operating cash flow-$75.4M+12.3%
CapEx$1.8M+58.4%
Free cash flow-$77.1M+11.4%

Valuation

See full
Market cap$7.71B+208%
Enterprise value$7.95B+187%
P/S54.7×-25.4×

Profitability

See full
Gross margin99.3%-0.5pp
Operating margin-185.4%-83.3pp
Net margin-606.2%-212pp
FCF margin-212%-95.8pp

Returns & leverage

See full
Return on equity-119.3%
Debt / equity0.1×
Current ratio6.7×+4.4×

Where this comes from

Calculated from ImmunityBio, Inc.’s reported figures.

Based on trailing twelve months.

The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ImmunityBio, Inc.'s inventory turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ImmunityBio, Inc.'s inventory turnover?
ImmunityBio, Inc. (IBRX) reported inventory turnover of 0.1× in Q1 2026.
What does inventory turnover mean?
Trailing-twelve-month cost of revenue divided by average inventory. Measures how many times inventory is sold and replaced over the year.